Oncology Data Advisor
J

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward

By Oncology Data Advisor FEATURING Jason Mouabbi, Ross Maclean, Michael Glover
By Oncology Data Advisor FEATURING Jason Mouabbi, Ross Maclean, Michael Glover
133 views
March 7, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
34:57
Total Health

2023 ASCO® Direct Philadelphia: Complementary & Integrative Ther…

Feat. B. DuPree
50:11
UNC Lineberger Comprehensive Cancer Center

Integrating Germline Pharmacogenomic Testing Into Oncology Care

Feat. A. Cipriani
11:51
ecancer

The Common Sense Movement in Oncology

Feat. V. Vanderpuye
12:22
Melanoma Bridge 2023

Drug Development in Melanoma: Phase I/II/III vs. Novel Designs

Feat. I. Puzanov
53:58
Masonic Cancer Center, University of Minnesota

Drug Targets and Synthetic Vulnerabilities in Sarcoma: Our Experienc…

Feat. D. Largaespada
20:03
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Developing Novel Classes of Therapeutics: Walking a Tightrope Withou…

Feat. K. High
53:57
University of Colorado Cancer Center

What Will It Take to Cure Cancer? Historical Context and Future Dire…

Feat. C. Lieu
39:49
Scripps MD Anderson Cancer Center

What’s New: Oncology Drug Updates - Part 1

Feat. M. Fox
09:58
Melanoma Bridge 2023

Drug Development in Melanoma: Why Do We Need Novel Trial Designs?

Feat. M. Khasraw
16:57
Scripps MD Anderson Cancer Center

What’s New: Oncology Drug Updates - Part 2

Feat. B. Do
30:04
Total Health

2023 ASCO® Direct Philadelphia: Artificial Intelligence in Cancer Ca…

Feat. A. Loaiza-Bonilla
22:43
Oncology Data Advisor

Understanding the Tumor Microenvironment to Unlock the Key to Oncolo…

Feat. J. Garcia
27:17
Yale Cancer Center

The Evolution of HIPEC in the Treatment of Cancer

Feat. K. Turaga
10:43
University of Colorado Cancer Center

MET Signaling in NSCLC: Importance of Biomarker Development & Ba…

Feat. T. Patil
26:02
Indy Hematology Review

Recognizing Toxicities of Oral Oncolytics in the Management of Hemat…

Feat. K. Orbaugh
25:05
2022 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Consider Buprenorphine Based on Clinical Utility and Safety

Feat. A. Case
15:36
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

Curative Therapy for MM: What Have We Learned so Far, and How Does I…

Feat. A. Jakubowiak
06:25
Vivek Subbiah

2021 ASCO Update From the ARROW Trial: Clinical Activity and Safety …

26:45
2023 Johns Hopkins Updates in Gastrointestinal Cancers

2023 Johns Hopkins Updates in Gastrointestinal Cancers: Navigating C…

Feat. M. Pishvaian
08:10
ecancer

The Placebo Effect in Oncology Trials and the Criteria for Approving…

Feat. B. Gyawali